drug

aprepitant

1 story · latest Aug 10, 2026

Status: FDA approved Mar 2003 · NDA021549, NDA207865, NDA209296, NDA216457, NDA218754
Brands: Aponvie, Cinvanti

Relationships

Developed by Merck & Co., Inc.

Timeline

Heron withdraws 2026 guidance, weighs strategic alternatives after CINVANTI ruling

Aug 10Quarterly updateaprepitant Heron Therapeutics, Inc. /De/

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.